Valuation Update With 7 Day Price Move • 1h
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to ₩36,800, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 8x in the Chemicals industry in South Korea. Total returns to shareholders of 47% over the past three years. Valuation Update With 7 Day Price Move • Jun 16
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₩50,700, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 115% over the past three years. Valuation Update With 7 Day Price Move • Jun 02
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₩41,300, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 85% over the past three years. Valuation Update With 7 Day Price Move • May 15
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₩45,900, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 118% over the past three years. Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩55,900, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 160% over the past three years. Valuation Update With 7 Day Price Move • Mar 31
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₩46,700, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 121% over the past three years. Reported Earnings • Mar 20
Full year 2025 earnings released: EPS: ₩3,635 (vs ₩2,365 in FY 2024) Full year 2025 results: EPS: ₩3,635 (up from ₩2,365 in FY 2024). Revenue: ₩670.9b (up 15% from FY 2024). Net income: ₩51.9b (up 54% from FY 2024). Profit margin: 7.7% (up from 5.8% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 33% per year whereas the company’s share price has increased by 38% per year. 공시 • Mar 10
ENF Technology Co., Ltd., Annual General Meeting, Mar 24, 2026 ENF Technology Co., Ltd., Annual General Meeting, Mar 24, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 299, hyowon-ro, paldal-gu, gyeonggi-do, suwon South Korea Price Target Changed • Feb 19
Price target increased by 18% to ₩72,000 Up from ₩61,000, the current price target is provided by 1 analyst. New target price is 23% above last closing price of ₩58,300. Stock is up 132% over the past year. The company posted earnings per share of ₩2,364 last year. Valuation Update With 7 Day Price Move • Jan 28
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₩54,900, the stock trades at a trailing P/E ratio of 14.4x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 139% over the past three years. Upcoming Dividend • Dec 22
Upcoming dividend of ₩150 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 22 April 2026. Payout ratio is a comfortable 3.9% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%). Reported Earnings • Nov 19
Third quarter 2025 earnings released: EPS: ₩1,113 (vs ₩737 in 3Q 2024) Third quarter 2025 results: EPS: ₩1,113 (up from ₩737 in 3Q 2024). Revenue: ₩172.1b (up 14% from 3Q 2024). Net income: ₩15.9b (up 51% from 3Q 2024). Profit margin: 9.2% (up from 6.9% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth. Declared Dividend • Nov 08
Dividend of ₩150 announced Dividend of ₩150 is the same as last year. Ex-date: 29th December 2025 Payment date: 22nd April 2026 Dividend yield will be 0.3%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 4%. Cash payout ratio: 6%. 공시 • Nov 07
ENF Technology Co., Ltd. announces Annual dividend, payable on April 22, 2026 ENF Technology Co., Ltd. announced Annual dividend of KRW 150.0000 per share payable on April 22, 2026, ex-date on December 29, 2025 and record date on December 31, 2025. Valuation Update With 7 Day Price Move • Oct 03
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩61,700, the stock trades at a trailing P/E ratio of 18x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 169% over the past three years. Price Target Changed • Sep 19
Price target increased by 11% to ₩61,000 Up from ₩55,000, the current price target is provided by 1 analyst. New target price is 16% above last closing price of ₩52,400. Stock is up 138% over the past year. The company posted earnings per share of ₩2,364 last year. Valuation Update With 7 Day Price Move • Sep 09
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩41,500, the stock trades at a trailing P/E ratio of 12.1x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 45% over the past three years. New Risk • Sep 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.7% average weekly change). New Risk • Jul 23
New major risk - Revenue and earnings growth Earnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Jun 26
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₩39,200, the stock trades at a trailing P/E ratio of 13x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 38% over the past three years. Reported Earnings • Mar 21
Full year 2024 earnings released: EPS: ₩2,365 (vs ₩1,220 loss in FY 2023) Full year 2024 results: EPS: ₩2,365 (up from ₩1,220 loss in FY 2023). Revenue: ₩582.4b (up 9.7% from FY 2023). Net income: ₩33.8b (up ₩51.2b from FY 2023). Profit margin: 5.8% (up from net loss in FY 2023). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. 공시 • Mar 11
ENF Technology Co., Ltd., Annual General Meeting, Mar 25, 2025 ENF Technology Co., Ltd., Annual General Meeting, Mar 25, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 299, hyowon-ro, paldal-gu, gyeonggi-do, suwon South Korea Upcoming Dividend • Dec 20
Upcoming dividend of ₩50.00 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 21 April 2025. Payout ratio is a comfortable 38% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%). New Risk • Dec 09
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. This is currently the only risk that has been identified for the company. New Risk • Jun 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.8x net interest cover). Earnings have declined by 24% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.0% average weekly change). New Risk • May 29
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 2.8x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.8x net interest cover). Earnings have declined by 24% per year over the past 5 years. Reported Earnings • Mar 22
Full year 2023 earnings released: ₩1,224 loss per share (vs ₩3,276 profit in FY 2022) Full year 2023 results: ₩1,224 loss per share (down from ₩3,276 profit in FY 2022). Revenue: ₩574.8b (down 16% from FY 2022). Net loss: ₩17.5b (down 137% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings. Upcoming Dividend • Dec 20
Upcoming dividend of ₩150 per share at 0.6% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 24 April 2024. Payout ratio is a comfortable 33% but the company is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%). Upcoming Dividend • Dec 21
Upcoming dividend of ₩150 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 24 April 2023. Payout ratio is a comfortable 4.4% but the company is not cash flow positive. Trailing yield: 0.7%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%). Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 2 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Jul 21
Investor sentiment improved over the past week After last week's 15% share price gain to ₩29,800, the stock trades at a trailing P/E ratio of 17.5x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 54% over the past three years. Valuation Update With 7 Day Price Move • Jun 23
Investor sentiment deteriorated over the past week After last week's 18% share price decline to ₩27,950, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 38% over the past three years. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 2 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Apr 12
Investor sentiment improved over the past week After last week's 19% share price gain to ₩33,650, the stock trades at a trailing P/E ratio of 26x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 74% over the past three years. Upcoming Dividend • Dec 22
Upcoming dividend of ₩150 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 21 April 2022. Payout ratio is a comfortable 9.6% but the company is not cash flow positive. Trailing yield: 0.5%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.4%). Valuation Update With 7 Day Price Move • Nov 30
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₩27,350, the stock trades at a trailing P/E ratio of 17.6x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 108% over the past three years. Price Target Changed • May 20
Price target decreased to ₩43,000 Down from ₩54,000, the current price target is provided by 1 analyst. New target price is 15% above last closing price of ₩37,300. Stock is up 21% over the past year. Is New 90 Day High Low • Mar 05
New 90-day low: ₩39,950 The company is down 5.0% from its price of ₩41,850 on 04 December 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. Is New 90 Day High Low • Jan 21
New 90-day high: ₩48,200 The company is up 35% from its price of ₩35,800 on 23 October 2020. The South Korean market is up 31% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 39% over the same period. Is New 90 Day High Low • Dec 15
New 90-day high: ₩46,050 The company is up 4.0% from its price of ₩44,100 on 16 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. Is New 90 Day High Low • Oct 15
New 90-day low: ₩39,450 The company is down 8.0% from its price of ₩42,900 on 17 July 2020. The South Korean market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 25% over the same period.